A Trial to Learn How a New Liquid Form of Rivaroxaban Behaves and How Safe it is Compared to the Current Tablet Form of Rivaroxaban in Healthy Male Participants

NCT04720092 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Thromboembolic Disorders

Interventions

DRUG: Rivaroxaban (Xarelto, BAY59-7939)
DRUG: Rivaroxaban (Xarelto, BAY59-7939)

Sponsor

Bayer

Collaborators

[object Object]